Cancer morbidity in patients with cardiac dysfunction with left ventricular ejection fraction <50%

Cancer morbidity in patients with cardiac dysfunction with left ventricular ejection fraction <50% - Cancer morbidity in patients with cardiac dysfunction

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043297

Enrollment

3000

Registered

2021-02-10

Start date

2019-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with echocardiographic evidence of left ventricular ejection fraction of 50% or less

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Cancer morbidity of patients with cardiac dysfunction	—

Countries

Japan

Contacts

Public ContactShinya Fujiki

Niigata University Graduate School of Medical and Dental Sciences Department of Cardiovascular Biology and Medicine

sfujiki@med.niigata-u.ac.jp025-227-2185

Outcome results